Processa Pharmaceuticals, Inc. PCSA
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity lost 373 cents this year.
The 14-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | ◌ | ◌ | ◌ | 0.0 | 0.0 | ◌ | ◌ | ◌ | ◌ | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Income tax $B | ◌ | ◌ | ◌ | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | ◌ | −0.0 | −0.0 | −0.0 | −0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | ◌ | −0.0 | −0.0 | ◌ | ◌ | ◌ | ◌ | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −10.36 | −96.78 | −8.48 | −34.05 | −0.75 | −2.54 | −0.70 | −0.71 | −0.06 | −0.07 | −0.31 | −0.68 | −0.61 | −1.50 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % | — | — | — | — | — | — | — | — | — | — | −1 | −1 | — | — |
| ROE % | −373.0 | −354.5 | −178.5 | −166.4 | −47.2 | −93.1 | −37.9 | −74.7 | — | — | — | −314.5 | −145.0 | −95.2 |
| Shares out B | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 14 of the 14 fiscal years we could check. 10 checks were skipped: the balance sheet is not tagged before 2012. Five checks were skipped: EPS is not tagged before 2012. Five checks were skipped: revenue is not tagged before 2012.